Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 21 (KRT18P21) is a processed pseudogene related to the functional KRT18 gene, which encodes keratin 18—a key intermediate filament protein important in epithelial cell structure and function. KRT18P21, like many keratin pseudogenes, is the product of gene duplication and retrotransposition but does not retain an intact open reading frame and does not produce protein[1][5]. Its sequence is similar to the functional KRT18 gene, but it is generally considered nonfunctional and is dispersed in the human genome among many other keratin 18 pseudogenes. There is no evidence that KRT18P21 is transcribed into a functional RNA or involved in disease processes, drug interactions, or cellular pathways[1][5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 21 (KRT18P21).